Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
55%
Ph phase_4
2
18%
Ph phase_3
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Other(2)

Detailed Status

Completed8
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (27.3%)
Phase 42 (18.2%)
N/A6 (54.5%)

Trials by Status

completed873%
recruiting19%
unknown218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11